FDA News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

FDA approves first two-drug regimen for certain patients with HIV - FDA.gov



Fox News
 
FDA approves first two-drug regimen for certain patients with HIV 
FDA.gov
The U.S. Food and Drug Administration today approved Juluca, the first complete treatment regimen containing only two drugs to treat certain adults with human immunodeficiency virus type 1 (HIV-1) instead of three or more drugs included in standard HIV ...
FDA approves first 2-drug HIV regimen Fox News
Pharmalittle: FDA pursues pharmacies that help internet orders; will Vioxx return? STAT
US FDA Approves First Two-drug HIV Regimen in Win for GSK Medscape
Daily Mail  -P&T Community  -Nasdaq 
all 47 news articles » 


FDA approves first implanted lens that can be adjusted after cataract surgery to improve vision without eyeglasses ... - FDA.gov



FDA approves first implanted lens that can be adjusted after cataract surgery to improve vision without eyeglasses ... 
FDA.gov
?Until now, refractive errors that are common following cataract surgery could only be corrected with glasses, contact lenses or refractive surgery,? said Malvina Eydelman, M.D., director of the Division of Ophthalmic, and Ear, Nose and Throat at the ...

and more » 


MediWound: Doubling Sales Even Before Likely FDA Approval - Seeking Alpha



MediWound: Doubling Sales Even Before Likely FDA Approval 
Seeking Alpha
MediWound's stock has taken a beating following a share issuance and 2 previous lackluster quarterly earnings. I believe that with the real-life effectiveness showing of the company's key product NexoBrid, the FDA case has a very high chance of approval.

 


Statement from FDA Commissioner Scott Gottlieb, MD, on steps to promote development of generic versions of opioids ... - FDA.gov



Washington Times
 
Statement from FDA Commissioner Scott Gottlieb, MD, on steps to promote development of generic versions of opioids ... 
FDA.gov
As we continue to confront the staggering human and economic toll created by opioid abuse and addiction, we're focused on taking actions that reduce the scope of new addiction by decreasing unnecessary exposure to opioids. At the same time, we also ...
FDA issues guidance on development of generic abuse-deterrent opioids Seeking Alpha
FDA pushes companies to develop opioids that resist abuse Washington Times

all 8 news articles » 


FDA issues final guidelines for generic abuse-deterrent opioids - STAT



STAT
 
FDA issues final guidelines for generic abuse-deterrent opioids 
STAT
By encouraging production of such medicines, the agency hopes to mitigate the extent to which individuals misuse opioids while simultaneously lowering prescription drug costs, a wider goal that FDA officials have adopted in recent months. This is a ...
FDA pushes for more abuse-deterrent opioid generics BioPharma Dive
FDA encourages cheap abuse-deterrent painkillers pharmaphorum
FDA's Gottlieb on Promoting Generic Opioids to Curb Abuse Healthcare Packaging
The Pharma Letter  -Nutritional Outlook  -Pain Medicine News 
all 11 news articles » 


It's not the chicken, it's the adobo: Hundreds of spices recalled after FDA warns of Salmonella fears - Daily Mail



Daily Mail
 
It's not the chicken, it's the adobo: Hundreds of spices recalled after FDA warns of Salmonella fears 
Daily Mail
Two of American food producer Goya's adobo spice mixtures have been recalled amid the FDA's fears of salmonella contamination. The FDA identified 661 cases of adobo with cumin and adobo with pepper spices distributed to Puerto Rico that may carry the ...

and more » 


Medicrea Receives FDA Clearance for 3D-Printed Titanium Interbody Devices and Introduces AdapTEK? Surgeon ... - Business Wire (press release)



Medicrea Receives FDA Clearance for 3D-Printed Titanium Interbody Devices and Introduces AdapTEK? Surgeon ... 
Business Wire (press release)
Denys Sournac, President and Chief Executive Officer, stated, ?With the FDA clearance of our 3D-printed Titanium interbodies, we are able to approach a large segment of the spine market, where we were not previously present, with an adaptive range of ...

and more » 


Debunking False Vaccine Claim - FactCheck.org



FactCheck.org
 
Debunking False Vaccine Claim 
FactCheck.org
The headline on the story says: ?NOW IT'S OFFICIAL: FDA Announced That Vaccines Are Causing Autism!? But the FDA has made no such announcement, and the only evidence that the story gives to support its claim is the label from a vaccine called Tripedia ...

and more » 


FDA lifts second trial hold for Prescient's lead drug, with one to go - FierceBiotech



FierceBiotech
 
FDA lifts second trial hold for Prescient's lead drug, with one to go 
FierceBiotech
In September the FDA lifted the stay on the phase 1b/2 AML trial, and followed suit on the ovarian cancer study this month, after Prescient tweaked the risk-management protocols in the studies and agreed to carry out more liver function tests. The ...

 


What will FDA's new rules mean for legitimate stem cell treatments? - STAT



STAT
 
What will FDA's new rules mean for legitimate stem cell treatments? 
STAT
hen the Food and Drug Administration last week 1 issued guidelines for investigative stem cell therapies, much of the attention fell to the agency's vow to crack down further 2 on unregulated clinics 3 offering potentially unsafe treatments. But the ...